agilon health (NYSE:AGL) Price Target Cut to $1.75 by Analysts at Citigroup

agilon health (NYSE:AGL) had its price objective trimmed by Citigroup from $2.50 to $1.75 in a report released on Wednesday morning,Benzinga reports. The firm currently has a sell rating on the stock.

Several other research firms also recently weighed in on AGL. TD Cowen reduced their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday. Royal Bank of Canada reissued an “outperform” rating and set a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday. Finally, Benchmark restated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $6.38.

agilon health Stock Up 0.8 %

AGL opened at $1.89 on Wednesday. The company has a fifty day moving average of $3.14 and a two-hundred day moving average of $4.90. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a fifty-two week low of $1.80 and a fifty-two week high of $13.76. The stock has a market capitalization of $776.66 million, a price-to-earnings ratio of -2.01 and a beta of 0.60.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the company posted ($0.06) EPS. On average, research analysts expect that agilon health will post -0.35 earnings per share for the current year.

Insider Activity

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of institutional investors have recently made changes to their positions in the stock. MetLife Investment Management LLC boosted its position in shares of agilon health by 114.8% during the third quarter. MetLife Investment Management LLC now owns 167,789 shares of the company’s stock worth $659,000 after buying an additional 89,675 shares during the period. Quantbot Technologies LP acquired a new position in agilon health during the 3rd quarter worth about $1,742,000. Dynamic Technology Lab Private Ltd purchased a new position in agilon health during the 3rd quarter valued at about $171,000. Algert Global LLC increased its stake in agilon health by 80.2% during the third quarter. Algert Global LLC now owns 184,530 shares of the company’s stock worth $725,000 after purchasing an additional 82,123 shares during the period. Finally, Citigroup Inc. increased its stake in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.